Sun Pharmaceutical Industries Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Sun Pharmaceutical Industries Limited's balance sheet done over the years? Its assets were worth $854,628,800,000 last year, which is more than in the previous period. 21% of Sun Pharmaceutical Industries Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $183,569,100,000, which means an decrease by -2% compared compared to last year.
Debt to Assets
| 2011 | 123142300000 | 19.83B | 16.11% |
|---|---|---|---|
| 2012 | 162603900000 | 29.32B | 18.04% |
| 2015 | 490279000000 | 205.38B | 41.89% |
| 2016 | 542195500000 | 187.29B | 34.54% |
| 2018 | 643028000000 | 223.18B | 34.71% |
| 2019 | 646938100000 | 199.71B | 30.87% |
| 2020 | 682524600000 | 191.27B | 28.03% |
| 2021 | 676667300000 | 181.86B | 26.88% |
| 2022 | 697998700000 | 187.33B | 26.84% |
| 2024 | 854628800000 | 183.56B | 21.48% |
SUNPHARMA.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 92.85B | 45.08B | 62.73B | 56.76B | 70.62B | 79.25B | 81.19B | 72.85B | 17.52B | 21.93B |
Short term investments | 100.43B | 81.46B | 32.90B | 52.63B | 41.16B | 60.51B | 65.84B | 58.29B | 32.38B | 0 |
Net receivables | 112.60B | 133.09B | 118.31B | 127.41B | 119.49B | 84.16B | 80.69B | 55.84B | 0 | 0 |
Inventory | 102.94B | 89.96B | 89.97B | 78.74B | 78.85B | 68.80B | 64.23B | 56.67B | 20.86B | 14.79B |
Other current assets | 28.29B | 540.9M | 508.2M | 974.3M | 548.4M | 29.62B | 24.21B | 100.84B | 30.62B | 23.44B |
Total current assets | 434.33B | 350.14B | 304.42B | 316.54B | 310.69B | 316.35B | 308.64B | 291.21B | 101.40B | 60.17B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 113.00B | 111.68B | 111.71B | 112.26B | 109.38B | 105.93B | 87.59B | 85.06B | 29.58B | 25.05B |
Goodwill | 85.98B | 65.49B | 62.87B | 64.81B | 59.55B | 56.06B | 55.93B | 50.61B | 10.21B | 7.71B |
Intangible assets | 86.66B | 60.28B | 56.60B | 63.59B | 63.53B | 51.17B | 31.88B | 11.52B | 3.16B | 2.88B |
Long term investments | 64.41B | 49.59B | 64.82B | 52.45B | 39.51B | -29.99B | -59.91B | -52.31B | -26.49B | 0 |
Other non-current assets | 69.81B | 31.82B | 40.66B | 41.10B | 38.70B | 121.54B | 81.94B | 74.61B | 34.34B | 22.30B |
Total non-current assets | 420.29B | 347.84B | 372.24B | 365.98B | 336.24B | 326.66B | 233.54B | 199.05B | 61.19B | 62.97B |
Total assets | 854.62B | 697.99B | 676.66B | 682.52B | 646.93B | 643.02B | 542.19B | 490.27B | 162.60B | 123.14B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 1.26B | 114.02B | 86.87B | 49.04B | 37.55B | 59.81B | 37.49B | 44.04B | 0 | 0 |
Short term debt | 29.70B | 8.08B | 29.70B | 62.85B | 89.91B | 86.13B | 53.86B | 76.38B | 1.69B | 0 |
Total current liabilities | 169.84B | 172.00B | 161.45B | 157.06B | 173.39B | 198.64B | 132.47B | 163.53B | 24.65B | 14.23B |
| Non-current liabilities: | ||||||||||
Long term debt | 3.03B | 4.81B | 8.98B | 20.28B | 15.22B | 17.72B | 31.10B | 13.68B | 1.55B | 4.25B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.34B |
Other non-current liabilities | 9.14B | 4.00B | 3.80B | 5.75B | 4.45B | 4.50B | 22.08B | 1.84B | 1.47B | 0 |
Total non-current liabilities | 13.73B | 15.33B | 20.41B | 34.21B | 26.31B | 24.53B | 54.81B | 41.85B | 4.66B | 5.60B |
Total liabilities | 183.56B | 187.33B | 181.86B | 191.27B | 199.71B | 223.18B | 187.29B | 205.38B | 29.32B | 19.83B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |